The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-Hydroxy-4-((3-(1-methyl-1H-imidazol-5-yl)-1H-indol-1-yl)-methyl)benzamide ID: ALA4541796
PubChem CID: 155551057
Max Phase: Preclinical
Molecular Formula: C20H18N4O2
Molecular Weight: 346.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cncc1-c1cn(Cc2ccc(C(=O)NO)cc2)c2ccccc12
Standard InChI: InChI=1S/C20H18N4O2/c1-23-13-21-10-19(23)17-12-24(18-5-3-2-4-16(17)18)11-14-6-8-15(9-7-14)20(25)22-26/h2-10,12-13,26H,11H2,1H3,(H,22,25)
Standard InChI Key: ANMZNMDSWZJYNP-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 29 0 0 0 0 0 0 0 0999 V2000
40.7302 -13.1122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7291 -13.9317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4371 -14.3407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1468 -13.9312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1439 -13.1086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4353 -12.7033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8551 -14.3387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.8564 -15.1559 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
43.5622 -13.9290 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
44.2705 -14.3365 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.0224 -12.7037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0222 -11.8865 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.4300 -10.6291 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.6811 -11.4036 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3605 -11.4066 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6136 -10.6333 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0710 -10.0295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2752 -10.1977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0249 -10.9752 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5691 -11.5757 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.9088 -9.9669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.7217 -9.9609 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
41.9725 -9.1831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3102 -8.7043 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.6503 -9.1862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.2052 -10.6197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
4 7 1 0
7 8 2 0
7 9 1 0
9 10 1 0
1 11 1 0
11 12 1 0
12 14 1 0
13 16 1 0
15 12 1 0
13 14 2 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
13 21 1 0
21 22 1 0
22 23 1 0
23 24 2 0
24 25 1 0
25 21 2 0
22 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 346.39Molecular Weight (Monoisotopic): 346.1430AlogP: 3.21#Rotatable Bonds: 4Polar Surface Area: 72.08Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.20CX Basic pKa: 6.04CX LogP: 2.54CX LogD: 2.52Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.44Np Likeness Score: -1.00
References 1. Géraldy M, Morgen M, Sehr P, Steimbach RR, Moi D, Ridinger J, Oehme I, Witt O, Malz M, Nogueira MS, Koch O, Gunkel N, Miller AK.. (2019) Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated., 62 (9): [PMID:30964290 ] [10.1021/acs.jmedchem.8b01936 ]